Phase 1 study of intravenous administration of the chimeric adenovirus enadenotucirev in patients undergoing primary tumor resection

Overview of attention for article published in Journal for Immunotherapy of Cancer, September 2017

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (93rd percentile)
High Attention Score compared to outputs of the same age and source (85th percentile)

So far, Dimensions has found 121 publications that cite this research output.

Article in Biomarker Research (March 2024)

Book chapter (March 2024)

Article in Molecular Biology Reports (March 2024)

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.